Current Research in Nanocarriers
A special issue of Journal of Functional Biomaterials (ISSN 2079-4983). This special issue belongs to the section "Biomaterials for Drug Delivery".
Deadline for manuscript submissions: 30 December 2024 | Viewed by 143
Special Issue Editors
Interests: nanocarriers; polymers; biomaterials; inorganic materials; drug delivery; gene therapy; diagnostics; cancer; inflammatory diseases; genetic disorders
Interests: nanocarriers; polymers; small molecules; gene therapy; skin disorders; cancer; inflammatory diseases
Special Issue Information
Dear Colleagues,
Welcome to this Special Issue on “Current Research in Nanocarriers” in the Journal of Functional Biomaterials. This Special Issue serves as a platform to explore the latest advancements and breakthroughs in the field of nanocarriers, focusing on their pivotal role in precision therapeutic applications. Nanocarriers have revolutionized targeted drug delivery, gene therapy, and diagnostics, offering unprecedented opportunities for personalized medicine in various disease contexts such as cancer, inflammatory diseases, genetic disorders, and infectious diseases.
We are pleased to invite researchers and experts from diverse disciplines to contribute their original research, reviews, and perspectives on the design, development, characterization, and application of polymer, biomaterial, and inorganic nanocarriers.
Topics of this Special Issue include, but are not limited to, the following:
- Synthesis of novel nanocarrier materials for hydrogel applications;
- Functionalization of nanocarriers for specific therapeutic purposes;
- Exploration of innovative delivery mechanisms and evaluation of the efficacy and safety profiles of nanocarriers;
- Utilization of nanocarriers for biosensors, diagnostic applications, and microfluidic platforms;
- Passive and active drug delivery using nanocarriers and gene therapy;
- Role of nanocarriers in personalized medicine;
- Nanocarrier applications in cancer therapy, inflammatory diseases, genetic disorders, and infectious diseases;
- Mechanistic understanding of nanocarrier drug product performance by contributing to the execution of in vitro/in vivo/ex vivo studies and utilizing advanced characterization tools.
Dr. Saurabh Sharma
Dr. Gautam Singhvi
Dr. Subhash Chander
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Functional Biomaterials is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery
- nanocarrier
- biomaterial
